danyelza - naxitamab injection
(Naxitamab)Y-Mabs Therapeutics, Inc.
Usage: Danyelza, with GM-CSF, treats pediatric patients (1 year and older) and adults with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who showed partial, minor, or stable response to prior therapy.